<DOC>
	<DOCNO>NCT00150202</DOCNO>
	<brief_summary>This study examine efficacy safety pegaptanib sodium Japanese patient wet-type AMD , order establish large difference efficacy safety drug Western Japanese patient .</brief_summary>
	<brief_title>Clinical Study Of EYE001 For Wet-Type AMD ( Age-Related Macular Degeneration )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>Wet AMD , Visual Acuity 20/320 20/40 Diabetic retinopathy , laser coagulation history</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>